Skip to main content
Addgene

SAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identifies DNA methylation as a vulnerability in ER-positive breast cancers.

Hosseinpour M, Xi X, Liu L, Malaver-Ortega L, Perlaza-Jimenez L, Joo JE, York HM, Beesley J, Caldon CE, Dugue PA, Dowty JG, Arumugam S, Southey MC, Rosenbluh J
Nat Commun. 2024 Dec 1;15(1):10449. doi: 10.1038/s41467-024-54824-8. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
213164SAM-DNMT3A emptyEmpty vector (no sgRNA) for induction of global DNA methylation.
213165SAM-DNMT3A+sgGFPVector with sgGFP for induction of global DNA methylation.
213166SAM-DNMT3A+sgAAVS1_145Vector with sgAAVS1 for induction of global DNA methylation.
213167SAM-DNMT3A+sgAAVS1_118Vector with sgAAVS1 for induction of global DNA methylation.
213168SAM-DNMT3A-inactiveEmptyEmpty Vector (no sgRNA) used as a negative control (inactive DNMT3A) for induction of global DNA methylation.
213169SAM-DNMT3A-inactive+sgGFPVector with sgGFP used as a negative control (inactive DNMT3A) for induction of global DNA methylation.
213170SAM-DNMT3A-inactive+sgAAVS1_145Vector with sgAAVS1 used as a negative control (inactive DNMT3A) for induction of global DNA methylation.
213171SAM-DNMT3A-inactive+sgAAVS1_118Vector with sgAAVS1 used as a negative control (inactive DNMT3A) for induction of global DNA methylation.

Antibodies from Article